Buprenorphine Implementation: Addressing Common Challenges in Hospital and Clinic Settings - CME - Guideline Central

CME

Title
Buprenorphine Implementation: Addressing Common Challenges in Hospital and Clinic Settings
Link
Description
Buprenorphine Implementation: Addressing Common Challenges in Hospital and Clinic Settings is a one hour online course designed for clinicians involved in the treatment of opioid use disorder. This course equips healthcare professionals with advanced strategies to address the complex challenges of buprenorphine prescribing for opioid use disorder (OUD) in both hospital and clinic settings. Using case-based learning, participants will explore real-world scenarios where common clinical, patient-related, legal/regulatory, cost/insurance, and organizational barriers arise. The course will offer practical solutions for navigating these challenges, ensuring adherence to evidence-based practices and enhancing interdisciplinary collaboration. Learners will leave with a stronger understanding of how to optimize buprenorphine treatment across various healthcare environments, improving patient outcomes and overcoming common barriers to treatment.
Target Audience
The target audience for this advanced level course include: physicians, nurse practitioners/nurses, physician assistants, pharmacists, and other clinicians. Clinicians who see patients with addiction in primary care, emergency/urgent care, treatment center, or general psychiatry settings.
Learning Objectives
  • Upon completion of this educational activity, participants should be able to:
  • Differentiate between managing buprenorphine treatment for opioid use disorder in hospital and clinic settings.
  • Recognize common challenges related to clinical care, patient management, regulatory compliance, and organizational barriers in buprenorphine treatment for OUD in hospital and clinic settings.
  • Apply practical strategies to overcome these challenges in both hospital and clinic settings.
Estimated Duration
60 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Pain Medicine, Internal Medicine - General, Family Medicine, Critical Care
Professions
Physician
Keywords
buprenorphine
Additional Information
DEA Education Requirement: As an accredited organization named in Section 1263 of the Consolidated Appropriations Act of 2023, ASAM certifies that the completion of this course counts toward meeting the DEA requirement for 8 hours of education on substance use disorder(s).
Disclosures and Disclaimers
Accreditation Statement: The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation Statement: The American Society of Addiction Medicine designates this Course activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Accredited Providers
  • Accreditation Council for Continuing Medical Education
Activity Expiration Date
February 24, 2028
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit1 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.